Esnouf R - Search Results

1

1,1,3-Trioxo-2H,4H-thieno[3,4-e][1,2,4]thiadiazine (TTD) derivatives: a new class of nonnucleoside human immunodeficiency virus type 1 (HIV-1) reverse transcriptase inhibitors with anti-HIV-1 activity.

Witvrouw M, Arranz ME, Pannecouque C, Declercq R, Jonckheere H, Schmit JC, Vandamme AM, Diaz JA, Ingate ST, Desmyter J, Esnouf R, Van Meervelt L, Vega S, Balzarini J, De Clercq E. Witvrouw M, et al. Among authors: esnouf r. Antimicrob Agents Chemother. 1998 Mar;42(3):618-23. doi: 10.1128/AAC.42.3.618. Antimicrob Agents Chemother. 1998. PMID: 9517942 Free PMC article.

2

Susceptibility of feline immunodeficiency virus/human immunodeficiency virus type 1 reverse transcriptase chimeras to non-nucleoside RT inhibitors.

Auwerx J, Esnouf R, De Clercq E, Balzarini J. Auwerx J, et al. Among authors: esnouf r. Mol Pharmacol. 2004 Jan;65(1):244-51. doi: 10.1124/mol.65.1.244. Mol Pharmacol. 2004. PMID: 14722257

3

Characteristics of the Pro225His mutation in human immunodeficiency virus type 1 (HIV-1) reverse transcriptase that appears under selective pressure of dose-escalating quinoxaline treatment of HIV-1.

Pelemans H, Esnouf R, Dunkler A, Parniak MA, Vandamme AM, Karlsson A, De Clercq E, Kleim JP, Balzarini J. Pelemans H, et al. Among authors: esnouf r. J Virol. 1997 Nov;71(11):8195-203. doi: 10.1128/JVI.71.11.8195-8203.1997. J Virol. 1997. PMID: 9343170 Free PMC article.

4

A novel mutation (F227L) arises in the reverse transcriptase of human immunodeficiency virus type 1 on dose-escalating treatment of HIV type 1-infected cell cultures with the nonnucleoside reverse transcriptase inhibitor thiocarboxanilide UC-781.

Balzarini J, Pelemans H, Esnouf R, De Clercq E. Balzarini J, et al. Among authors: esnouf r. AIDS Res Hum Retroviruses. 1998 Feb 10;14(3):255-60. doi: 10.1089/aid.1998.14.255. AIDS Res Hum Retroviruses. 1998. PMID: 9491916

5

Mutational analysis of trp-229 of human immunodeficiency virus type 1 reverse transcriptase (RT) identifies this amino acid residue as a prime target for the rational design of new non-nucleoside RT inhibitors.

Pelemans H, Esnouf R, De Clercq E, Balzarini J. Pelemans H, et al. Among authors: esnouf r. Mol Pharmacol. 2000 May;57(5):954-60. Mol Pharmacol. 2000. PMID: 10779379

6

Mutations in the non-nucleoside binding-pocket interfere with the multi-nucleoside resistance phenotype.

Van Laethem K, Witvrouw M, Pannecouque C, Van Remoortel B, Schmit JC, Esnouf R, Kleim JP, Balzarini J, Desmyter J, De Clercq E, Vandamme AM. Van Laethem K, et al. Among authors: esnouf r. AIDS. 2001 Mar 30;15(5):553-61. doi: 10.1097/00002030-200103300-00003. AIDS. 2001. PMID: 11316991 Free article.

7

Mutations at amino acid positions 63, 189, and 396 of human immunodeficiency virus type 1 reverse transcriptase (RT) partially restore the DNA polymerase activity of a Trp229Tyr mutant RT.

Pelemans H, Esnouf R, Min KL, Parniak M, De Clercq E, Balzarini J. Pelemans H, et al. Among authors: esnouf r. Virology. 2001 Aug 15;287(1):143-50. doi: 10.1006/viro.2001.1032. Virology. 2001. PMID: 11504549 Free article.

8

Models which explain the inhibition of reverse transcriptase by HIV-1-specific (thio)carboxanilide derivatives.

Esnouf RM, Stuart DI, De Clercq E, Schwartz E, Balzarini J. Esnouf RM, et al. Biochem Biophys Res Commun. 1997 May 19;234(2):458-64. doi: 10.1006/bbrc.1997.6552. Biochem Biophys Res Commun. 1997. PMID: 9177293

9

A proline-to-histidine substitution at position 225 of human immunodeficiency virus type 1 (HIV-1) reverse transcriptase (RT) sensitizes HIV-1 RT to BHAP U-90152.

Pelemans H, Esnouf RM, Parniak MA, Vandamme AM, De Clercq E, Balzarini J. Pelemans H, et al. Among authors: esnouf rm. J Gen Virol. 1998 Jun;79 ( Pt 6):1347-52. doi: 10.1099/0022-1317-79-6-1347. J Gen Virol. 1998. PMID: 9634074

10

Mutational analysis of Tyr-318 within the non-nucleoside reverse transcriptase inhibitor binding pocket of human immunodeficiency virus type I reverse transcriptase.

Pelemans H, Esnouf RM, Jonckheere H, De Clercq E, Balzarini J. Pelemans H, et al. Among authors: esnouf rm. J Biol Chem. 1998 Dec 18;273(51):34234-9. doi: 10.1074/jbc.273.51.34234. J Biol Chem. 1998. PMID: 9852086 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

73 results

Search Page

Filters